PDPK1: 3-Phosphoinositide-Dependent Protein Kinase 1

A master kinase in PI3K/AKT signaling, central to cell growth, survival, and metabolism.

Gene Information Card

Symbol PDPK1
Full Name 3-phosphoinositide dependent protein kinase 1
Gene Type protein-coding
Chromosomal Location 16p13.3
NCBI Gene ID 5170 ncbi.nlm.nih.gov/gene/5170
Ensembl ID ENSG00000140992
UniProt ID O15530
OMIM ID 605213
HGNC ID 8816
Aliases PDK1, PDPK2P, PRO0461

Description

PDPK1 encodes 3-phosphoinositide-dependent protein kinase 1 (PDK1), a master kinase that phosphorylates and activates members of the AGC kinase family, including AKT, PKC, S6K, and SGK. PDK1 is a key mediator of PI3K signaling, regulating cell growth, proliferation, survival, and metabolism. Its activity is controlled by membrane localization and phosphorylation at Ser241. Dysregulation of PDPK1 is implicated in various cancers and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) Overexpression or gain-of-function mutations lead to constitutive activation of AKT and downstream survival pathways, promoting tumorigenesis. COSMIC; PMID: 22926525
Breast cancer Amplification and overexpression of PDPK1 correlate with poor prognosis and resistance to therapy. ClinVar; PMID: 20516152
Non-small cell lung cancer Activating mutations and increased PDK1 activity drive AKT signaling and cell proliferation. COSMIC; PMID: 24013665
Glioblastoma PDK1 overexpression enhances PI3K/AKT signaling, contributing to tumor growth and invasion. PMID: 21502544
Prostate cancer Elevated PDPK1 expression associated with aggressive disease and metastasis. PMID: 21947067
Type 2 diabetes Impaired PDK1 signaling in insulin-responsive tissues contributes to insulin resistance. OMIM: 605213; PMID: 16601693

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Medium
Liver 6.1 Low
Kidney 7.9 Medium
Lung 9.2 Medium
Pancreas 5.4 Low
Skeletal muscle 10.1 Medium
Testis 14.8 High
Cell Line Expression
Cell Line nTPM Notes
HeLa 11.3 Cervical cancer cell line
A549 9.8 Lung cancer cell line
MCF7 10.5 Breast cancer cell line
HEK293 8.7 Embryonic kidney cell line
K562 7.2 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.721C>T (p.Arg241Trp) Missense 0.2% (COSMIC) Potential gain-of-function; alters kinase domain
c.1100A>G (p.Tyr367Cys) Missense 0.1% (COSMIC) Unknown significance
c.1438G>A (p.Gly480Arg) Missense 0.05% (COSMIC) Likely loss-of-function
Amplification Copy number gain ~3% (TCGA) Overexpression; associated with poor prognosis
Mutation functional classification

Loss of Function (LOF)

Rare missense mutations in the kinase domain (e.g., p.Gly480Arg) reduce catalytic activity and downstream signaling.

Gain of Function (GOF)

Amplification and certain missense mutations (e.g., p.Arg241Trp) enhance PDK1 activity, leading to constitutive AKT activation.

Dominant Negative (DN)

Not well documented; some kinase-dead mutants may exert dominant-negative effects by competing for substrates.

Pathways

• PI3K-Akt signaling pathway (KEGG: hsa04151)
• mTOR signaling pathway (KEGG: hsa04150)
• Insulin signaling pathway (KEGG: hsa04910)
• Fc epsilon RI signaling pathway (KEGG: hsa04664)
• T cell receptor signaling pathway (KEGG: hsa04660)

Protein Summary

PDK1 is a 556-amino acid serine/threonine kinase with an N-terminal kinase domain and a C-terminal pleckstrin homology (PH) domain. It is activated by PI3K-generated PIP3, which recruits PDK1 to the plasma membrane. PDK1 phosphorylates the activation loop of AGC kinases (e.g., AKT at Thr308), enabling their full activation. PDK1 also phosphorylates itself at Ser241 for stability. The protein is ubiquitously expressed and essential for embryonic development.

Related Products

Product name Cat.No. Species Gene ID
No Data
Contact Us
*
*
*
How did you hear about us: